Abstract
In numerous countries throughout the world active and passive tobacco smoking is an important factor in the development of cardiovascular disease and its associated mortality. In Germany, whereas 30,000 new cases of bronchial carcinoma are diagnosed in smokers every year, the corresponding annual figure for new cases of coronary heart disease (CHD), hypertension, peripheral arterial occlusive disease (PAOD), stroke etc. among smokers is 80,000–90,000. The first epidemiological studies to demonstrate an association between cigarette smoking and ischaemic heart disease were the Framingham Study and a study in male British doctors [1, 2]. The Framingham Study additionally showed that the incidence of stroke is increased by smoking [2, 3]. Smoking is further associated with an increased risk for arteriosclerotic vascular changes and with the occurrence of cerebral aneurysms [3, 4]. While other risk factors such as hyperlipidaemia, hyperfibrinogenaemia and hypertension are important in the context of CHD, the development of PAOD and of aortic aneurysm is largely smoking-related [2, 5–7]. As long ago as 1944, research was published indicating that the effects of nicotine on the blood vessels differ clearly in quantitative (and qualitative) terms from those of inhaled tobacco smoke (Fig. 6.1), a finding that is also important with regard to the use of nicotine products to achieve smoking cessation [8, 9].
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Reference
Doll R, Peto R, Wheatley K, Gray R, Sutherland I (1994) Mortality in relation to smoking: 40 years’ observations on male British doctors. BMJ 309(6959):901–911
Hammond EC, Garfinkel L (1969) Coronary heart disease, roke, and aortic aneurysm. Factors in the etiology. Arch Environ Health 19(2):167–182
Abbott RD, Yin Y, Reed DM, Yano K (1986) Risk of stroke in male cigarette smokers. N Engl J Med 315(12):717–720
Adamson J, Humphries SE, Ostergaard JR, Voldby B, Richards P, Powell JT (1994) Are cerebral aneurysms atherosclerotic? Stroke 25(5):963–966
Fitzgerald GA, Oates JA, Nowak J (1988) Cigarette smoking and hemostatic function. Am Heart J 115(1 Pt 2):267–271
Fowkes FG (1988) Epidemiology of atherosclerotic arterial disease in the lower limbs. Eur J Vasc Surg 2(5):283–291
Kannel WB, Shurtleff D (1973) The Framingham study. Cigarettes and the development of intermittent claudication. Geriatrics 28(2):61–68
Haustein KO (1999) Smoking, cardiovascular diseases and possibilities for treating nicotine dependence. Wien Med Wochenschr 149(1):19–24
Haustein KO, Krause J, Haustein H, Rasmussen T, Cort N (2002) Effects of cigarette smoking or nicotine replacement on cardiovascular risk factors and parameters of haemorheology. J Intern Med 252(2):130–139
LaCroix AZ, Lang J, Scherr P, Wallace RB, Cornoni-Huntley J, Berkman L, et al (1991) Smoking and mortality among older men and women in three communities. N Engl J Med 324(23):1619–1625
Rosenberg L, Kaufman DW, Helmrich SP, Shapiro S (1985) The risk of myocardial infarction after quitting smoking in men under 55 years of age. N Engl J Med 313(24):1511–1514
US Department of Health and Human Services (1990). The Health Benefits of Smoking Cessation: A Report of the Surgeon General. US Department of Health and Human Services, Public Health Service, Center for Disease Control, Office on Smoking and Health. DHHS Publication No. (CDC) 908416
Seltzer CC (1974) Effect of smoking on blood pressure Am Heart J 87(5):558–564
Shah PK, Helfant RH (1988) Smoking and coronary artery disease. Chest 94(3):449–452
Kawachi I, Colditz GA, Stampfer MJ, Willett WC, Manson JE, Rosner B, et al (1993) Smoking cessation in relation to total mortality rates in women. A prospective cohort study. Ann Intern Med 119(10):992–1000
Aberg A, Bergstrand R, Johansson S, Ulvenstam G, Vedin A, Wedel H, et al (1983) Cessation of smoking after myocardial infarction. Effects on mortality after 10 years. Br Heart J 49(5):416–422
Daly LE, Mulcahy R, Graham IM, Hickey N (1983) Long term effect on mortality of stopping smoking after unstable angina and myocardial infarction. Br Med J (Clin Res Ed) 287(6388):324–326
Hallstrom AP, Cobb LA, Ray R (1986) Smoking as a risk factor for recurrence of sudden cardiac arrest. N Engl J Med 314(5):271–275
Sparrow D, Dawber TR (1978) The influence of cigarette smoking on prognosis after a first myocardial infarction. A report from the Framingham study. J Chronic Dis 31(6–7):425–432
Galan KM, Deligonul U, Kern MJ, Chaitman BR, Vandormael MG (1988) Increased frequency of restenosis in patients continuing to smoke cigarettes after percutaneous transluminal coronary angioplasty. Am J Cardiol 61(4):260–263
Taira DA, Seto TB, Ho KK, Krumholz HM, Cutlip DE, Berezin R, et al (2000) Impact of smoking on health-related quality of life after percutaneous coronary revascularization. Circulation 102:1369–1374
Kannel WB (1981) Update on the role of cigarette smoking in coronary artery disease. Am Heart J 101:319–328
Schievelbein H, Londong V, Londong W, Grumbach H, Remplik V (1970) Nicotine and arteriosclerosis. An experimental contribution to the influence of nicotine on fat metabolism. Z Klin Chem Klin Biochem 8:190–196
Schievelbein H, Richter F (1984) The influence of passive smoking on the cardiovascular system. Prev Med 13:626–644
Majesky MW, Reidy MA, Benditt EP, Juchau MR (1985) Focal smooth muscle proliferation in the aortic intima produced by an initiation-promotion sequence. Proc Natl Acad Sci USA 82:3450–3454
Bond JA, Gown AM, Yang HL, Benditt EP, Juchau MR (1981) Further investigations of the capacity of polynuclear aromatic hydrocarbons to elicit atherosclerotic lesions. J Toxicol Environ Health 7:327–335
Ross R, Glomset J, Harker L (1978). The response to injury and atherogenesis: The role of endothelium and smooth muscle. In: Paoletti R, Gotto AM (eds) Atherosclerosis Reviews, vol 3. New York, Raven Press, pp 69–76
Ross R (1986) The pathogenesis of atherosclerosis – an update. N Engl J Med 314:488–500
Majesky MW, Yang HY, Benditt EP, Juchau MR (1983) Carcinogenesis and atherogenesis: differences in monooxygenase inducibility and bioactivation of benzo[a]pyrene in aortic and hepatic tissues of atherosclerosis-susceptible versus resistant pigeons. Carcinogenesis 4:647–652
Penn A, Batastini G, Soloman J, Burns F, Albert R (1981) Dose-dependent size increases of aortic lesions following chronic exposure to 7,12-dimethylbenz(a)anthracene. Cancer Res 41:588–592
Bond JA, Yang HY, Majesky MW, Benditt EP, Juchau MR (1980) Metabolism of benzo[a]pyrene and 7,12-dimethylbenz[a]anthracene in chicken aortas: monooxygenation, bioactivation to mutagens, and covalent binding to DNA in vitro. Toxicol Appl Pharmacol 52:323–335
Bond JA, Kocan RM, Benditt EP, Juchau MR (1979) Metabolism of benzo[a]pyrene and 7,12-dimethylbenz[a]anthracene in cultured human fetal aortic smooth muscle cells. Life Sci 25:425–430
Davis JW, Shelton L, Eigenberg DA, Hignite CE, Watanabe IS (1985) Effects of tobacco and non-tobacco cigarette smoking on endothelium and platelets. Clin Pharmacol Ther 37:529–533
Brown DW, Giles WH, Croft JB (2001) Hematocrit and the risk of coronary heart disease mortality. Am Heart J 142(4):657–663
McBride PE (1992) The health consequences of smoking. Cardiovascular diseases. Med Clin North Am 76(2):333–353
McGill HC Jr (1988) The cardiovascular pathology of smoking. Am Heart J 115(1 Pt 2):250–257
Quillen JE, Rossen JD, Oskarsson HJ, Minor RL Jr, Lopez AG, Winniford MD (1993) Acute effect of cigarette smoking on the coronary circulation: constriction of epicardial and resistance vessels. J Am Coll Cardiol 22(3):642–647
Cryer PE, Haymond MW, Santiago JV, Shah SD (1976) Norepinephrine and epinephrine release and adrenergic mediation of smoking-associated hemodynamic and metabolic events. N Engl J Med 295(11):573–577
Glisic S, Savic I, Alavantic D (1995) Apolipoprotein B gene DNA polymorphisms (EcoRI and MspI) and serum lipid levels in the Serbian healthy population: interaction of rare alleles and smoking and cholesterol levels. Genet Epidemiol 12(5):499–508
Klein LW, Pichard AD, Holt J, Smith H, Gorlin R, Teichholz LE (1983) Effects of chronic tobacco smoking on the coronary circulation. J Am Coll Cardiol 1(2 Pt 1):421–426
Pittilo RM, Clarke JM, Harris D, Mackie IJ, Rowles PM, Machin SJ, et al (1984) Cigarette smoking and platelet adhesion. Br J Haematol 58(4):627–632
Maouad J, Fernandez F, Barrillon A, Gerbaux A, Gay J (1984) Diffuse or segmental narrowing (spasm) of the coronary arteries during smoking demonstrated on angiography. Am J Cardiol 53(2):354–355
Maouad J, Fernandez F, Hebert JL, Zamani K, Barrillon A, Gay J (1986) Cigarette smoking during coronary angiography: diffuse or focal narrowing (spasm) of the coronary arteries in 13 patients with angina at rest and normal coronary angiograms. Cathet Cardiovasc Diagn 12(6):366–375
Sugiishi M, Takatsu F (1993) Cigarette smoking is a major risk factor for coronary spasm. Circulation 87(1):76–79
Bolinder G (1997) Smokeless tobacco – a less harmful alternative? In: Bollinger CT, Fagerstrom KO (eds) The Tobacco Epidemic. S. Karger, Basel, pp 199–212
Mancini GB, Henry GC, Macaya C, O’Neill BJ, Pucillo AL, Carere RG, et al (1996) Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. The TREND (trial on reversing endothelial dysfunction) study. Circulation 94(3):258–265
Pepine CJ, Schlaifer JD, Mancini GB, Pitt B, O’Neill BJ, Haber HE (1998) Influence of smoking status on progression of endothelial dysfunction. TREND Investigators. Trial on reversing endothelial dysfunction. Clin Cardiol 21(5):331–334
Celermajer DS, Adams MR, Clarkson P, Robinson J, McCredie R, Donald A, et al (1996) Passive smoking and impaired endothelium-dependent arterial dilatation in healthy young adults. N Engl J Med 334(3):150–154
Nitenberg A, Benvenuti C, Aptecar E, Antony I, Deleuze P, Loisance D et al (1993) Acetylcholine-induced constriction of angiographically normal coronary arteries is not time dependent in transplant recipients. Effects of stepwise infusion at 1, 6, 12 and more than 24 months after transplantation. J Am Coll Cardiol 22(1):151–158
Zeiher AM, Schachinger V, Minners J (1995) Long-term cigarette smoking impairs endothelium- dependent coronary arterial vasodilator function. Circulation 92(5):1094–1100
Voors AA, Oosterga M, Buikema H (1997) Dose-response relation between cigarette consumption and endothelial function (Abstr.). J Am Coll Cardiol 29(Suppl A):263A–264A
Waters D, Lesperance J, Gladstone P, Boccuzzi SJ, Cook T, Hudgin R, et al (1996) Effects of cigarette smoking on the angiographic evolution of coronary atherosclerosis. A Canadian Coronary Atherosclerosis Intervention Trial (CCAIT) Substudy. CCAIT Study Group. Circulation 94(4):614–621
Jarvis MJ, Belcher M, Vesey C, Hutchison DC (1986) Low cost carbon monoxide monitors in smoking assessment. Thorax 41(11):886–887
Anderson EW, Andelman RJ, Strauch JM, Fortuin NJ, Knelson JH (1973) Effect of low-level carbon monoxide exposure on onset and duration of angina pectoris. A study in ten patients with ischemic heart disease. Ann Intern Med 79(1):46–50
Mahmarian JJ, Moye LA, Nasser GA, Nagueh SF, Bloom MF, Benowitz NL, et al (1997) Nicotine patch therapy in smoking cessation reduces the extent of exercise-induced myocardial ischemia. J Am Coll Cardiol 30(1):125–130
Negri E, La Vecchia C, Nobili A, D’Avanzo B, Bechi S (1994) Cigarette smoking and acute myocardial infarction. A case-control study from the GISSI-2 trial. GISSI-EFRIM Investigators. Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto - Epidemiologia dei Fattori di Rischio dell’infarto Miocardioco. Eur J Epidemiol 10(4):361–366
Beard CM, Kottke TE, Annegers JF, Ballard DJ (1989) The Rochester Coronary Heart Disease Project: effect of cigarette smoking, hypertension, diabetes, and steroidal estrogen use on coronary heart disease among 40- to 59-year-old women, 1960 through 1982. Mayo Clin Proc 64(12):1471–1480
Rosenberg L, Palmer JR, Shapiro S (1990) Decline in the risk of myocardial infarction among women who stop smoking. N Engl J Med 322(4):213–217
Vander ZR, Lemp GF, Hughes JP, Ramanathan KB, Sullivan JM, Schick EC et al (1988) The effect of cigarette smoking on the pattern of coronary atherosclerosis. A case-control study. Chest 94(2):290–295
Rosenberg L, Kaufman DW, Helmrich SP, Miller DR, Stolley PD, Shapiro S (1985) Myocardial infarction and cigarette smoking in women younger than 50 years of age. JAMA 253(20):2965–2969
Dunn NR, Faragher B, Thorogood M, de Caestecker L, MacDonald TM, McCollum C, et al (1999) Risk of myocardial infarction in young female smokers. Heart 82(5):581–583
McElduff P, Dobson A, Beaglehole R, Jackson R (1998) Rapid reduction in coronary risk for those who quit cigarette smoking. Aust N Z J Public Health 22(7):787–791
Weiner P, Waizman J, Weiner M, Rabner M, Magadle R, Zamir D (2000) Smoking and first acute myocardial infarction: age, mortality and smoking cessation rate. Isr Med Assoc J 2(6):446–449
Villarreal FJ, Hong D, Omens J (1999) Nicotine-modified postinfarction left ventricular remodeling. Am J Physiol 276(3 Pt 2):H1103–H1106
Heliovaara M, Karvonen MJ, Vilhunen R, Punsar S (1978) Smoking, carbon monoxide, and atherosclerotic diseases. Br Med J 1:268–270
Hughson WG, Mann JI, Tibbs DJ, Woods HF, Walton I (1978) Intermittent claudication: factors determining outcome. Br Med J 1:1377–1379
Doll R, Peto R (1976) Mortality in relation to smoking: 20 years’ observations on male British doctors. Br Med J 2:1525–1536
Doll R, Gray R, Hafner B, Peto R (1980) Mortality in relation to smoking: 22 years’ observations on female British doctors. Br Med J 280:967–971
Fowkes FG, Housley E, Riemersma RA, Macintyre CC, Cawood EH, Prescott RJ, et al (1992) Smoking, lipids, glucose intolerance, and blood pressure as risk factors for peripheral atherosclerosis compared with ischemic heart disease in the Edinburgh artery study. Am J Epidemiol 135(4):331–340
Price JF, Mowbray PI, Lee AJ, Rumley A, Lowe GD, Fowkes FG (1999) Relationship between smoking and cardiovascular risk factors in the development of peripheral arterial disease and coronary artery disease: Edinburgh artery study. Eur Heart J 20:344–353
Gudmundsson M, Bjelle A (1993) Plasma, serum and whole-blood viscosity variations with age, sex, and smoking habits. Angiology 44(5):384–391
Green MS, Jucha E, Luz Y (1986) Blood pressure in smokers and nonsmokers: epidemiologic findings. Am Heart J 111(5):932–940
Kool MJ, Hoeks AP, Struijker Boudier HA, Reneman RS, Van Bortel LM (1993) Short- and long-term effects of smoking on arterial wall properties in habitual smokers. J Am Coll Cardiol 22(7):1881–1886
Berlin I, Cournot A, Renout P, Duchier J, Safar M (1990) Peripheral haemodynamic effects of smoking in habitual smokers. A methodological study. Eur J Clin Pharmacol 38(1):57–60
Kyriakides ZS, Kremastinos DT, Rentoukas E, Mavrogheni S, Kremastinos DI, Toutouzas P (1992) Acute effects of cigarette smoking on left ventricular diastolic function. Eur Heart J 13(6):743–748
Stork T, Eichstadt H, Mockel M, Bortfeldt R, Muller R, Hochrein H (1992) Changes of diastolic function induced by cigarette smoking: an echocardiographic study in patients with coronary artery disease. Clin Cardiol 15(2):80–86
Tanus-Santos JE, Toledo JC, Cittadino M, Sabha M, Rocha JC, Moreno H Jr (2001) Cardiovascular effects of transdermal nicotine in mildly hypertensive smokers. Am J Hypertens 14(7 Pt 1):610–614
Gulliford MC (2001) Low rates of detection and treatment of hypertension among current cigarette smokers. J Hum Hypertens 15(11):771–773
Siegel D, Benowitz N, Ernster VL, Grady DG, Hauck WW (1992) Smokeless tobacco, cardiovascular risk factors, and nicotine and cotinine levels in professional baseball players. Am J Public Health 82(3):417–421
Mikkelsen KL, Wiinberg N, Hoegholm A, Christensen HR, Bang LE, Nielsen PE, et al (1997) Smoking related to 24-h ambulatory blood pressure and heart rate: a study in 352 normotensive Danish subjects. Am J Hypertens 10(5 Pt 1):483–491
Fox CS, Larson MG, Leip EP, Culleton B, Wilson PW, Levy D (2004) Predictors of new-onset kidney disease in a community-based population. JAMA 291(7):844–850
Mathew RJ, Wilson WH (1991) Substance abuse and cerebral blood flow. Am J Psychiatry 148(3):292–305
Rogers RL, Meyer JS, Shaw TG, Mortel KF, Hardenberg JP, Zaid RR (1983) Cigarette smoking decreases cerebral blood flow suggesting increased risk for stroke. JAMA 250(20):2796–2800
Colditz GA, Bonita R, Stampfer MJ, Willett WC, Rosner B, Speizer FE, et al (1988) Cigarette smoking and risk of stroke in middle-aged women. N Engl J Med 318(15):937–941
Wang H, Sekine M, Yokokawa H, Hamanishi S, Chen X, Sayama M, et al (2001) The relationship between new stroke onset and serum thiocyanate as an indicator to cigarette smoking. J Epidemiol 11(5):233–237
Silverberg E, Boring CC, Squires TS (1990) Cancer statistics, 1990. CA Cancer J Clin 40:9–26
Lederle FA, Johnson GR, Wilson SE, Chute EP, Hye RJ, Makaroun MS, et al (2000) The aneurysm detection and management study screening program: validation cohort and final results. Aneurysm detection and management veterans affairs cooperative study investigators. Arch Intern Med 160:1425–1430
Kanagasabay R, Gajraj H, Pointon L, Scott RA (1996) Co-morbidity in patients with abdominal aortic aneurysm. J Med Screen 3:208–210
Mattes E, Davis TM, Yang D, Ridley D, Lund H, Norman PE (1997) Prevalence of abdominal aortic aneurysms in men with diabetes. Med J Aust 166:630–633
Franks PJ, Edwards RJ, Greenhalgh RM, Powell JT (1996) Risk factors for abdominal aortic aneurysms in smokers. Eur J Vasc Endovasc Surg 11:487–492
Powell JT, Brown LC (2001) The natural history of abdominal aortic aneurysms and their risk of rupture. Acta Chir Belg 101:11–16
Vardulaki KA, Walker NM, Day NE, Duffy SW, Ashton HA, Scott RA (2000) Quantifying the risks of hypertension, age, sex and smoking in patients with abdominal aortic aneurysm. Br J Surg 87:195–200
Brown LC, Powell JT (1999) Risk factors for aneurysm rupture in patients kept under ultrasound surveillance. UK small aneurysm trial participants. Ann Surg 230:289–296
Fowkes FG, Macintyre CC, Ruckley CV (1989) Increasing incidence of aortic aneurysms in England and Wales. BMJ 298:33–35
Benowitz NL (1988) Drug therapy. Pharmacologic aspects of cigarette smoking and nicotine addition. N Engl J Med 319(20):1318–1330
Butler R, Morris AD, Struthers AD (2001) Cigarette smoking in men and vascular responsiveness. Br J Clin Pharmacol 52(2):145–149
Butler R, Morris AD, Struthers AD (2001) Lisinopril improves endothelial function in chronic cigarette smokers. Clin Sci (Lond) 101(1):53–58
Nitenberg A, Antony I (1999) Effects of nicotine gum on coronary vasomotor responses during sympathetic stimulation in patients with coronary artery stenosis. J Cardiovasc Pharmacol 34:694–699
Neunteufl T, Heher S, Kostner K, Mitulovic G, Lehr S, Khoschsorur G, et al (2002) Contribution of nicotine to acute endothelial dysfunction in long-term smokers. J Am Coll Cardiol 39:251–256
Park JE, Lee WH, Hwang TH, Chu JA, Kim S, Choi YH, et al (2000) Aging affects the association between endothelial nitric oxide synthase gene polymorphism and acute myocardial infarction in the Korean male population. Korean J Intern Med 15(1):65–70
Benowitz NL (1993) Smoking-induced coronary vasoconstriction: implications for therapeutic use of nicotine. J Am Coll Cardiol 22(3):648–649
Klein LW (1984) Cigarette smoking, atherosclerosis and the coronary hemodynamic response: a unifying hypothesis. J Am Coll Cardiol 4(5):972–974
Benowitz NL (1991) Nicotine and coronary heart disease. Trends Cardiovasc Med 1: 315–321
Munzel T, Hink U, Heitzer T, Meinertz T (1999) Role for NADPH/NADH oxidase in the modulation of vascular tone. Ann N Y Acad Sci 874:386–400
Papamichael CM, Aznaouridis KA, Stamatelopoulos KS, Karatzis EN, Protogerou AD, Papaioannou TG, et al (2004) Endothelial dysfunction and type of cigarette smoked: the impact of ‘light’ versus regular cigarette smoking. Vasc Med 9(2):103–105
Celermajer DS, Sorensen KE, Gooch VM, Spiegelhalter DJ, Miller OI, Sullivan ID, et al (1992) Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 340(8828):1111–1115
Heitzer T, Brockhoff C, Mayer B, Warnholtz A, Mollnau H, Henne S, et al (2000) Tetrahydrobiopterin improves endothelium-dependent vasodilation in chronic smokers: evidence for a dysfunctional nitric oxide synthase. Circ Res 86(2):E36–E41
Higman DJ, Strachan AM, Buttery L, Hicks RC, Springall DR, Greenhalgh RM, et al (1996) Smoking impairs the activity of endothelial nitric oxide synthase in saphenous vein. Arterioscler Thromb Vasc Biol 16(4):546–552
Ichiki K, Ikeda H, Haramaki N, Ueno T, Imaizumi T (1996) Long-term smoking impairs platelet-derived nitric oxide release. Circulation 94(12):3109–3114
Cosentino F, Katusic ZS (1995) Tetrahydrobiopterin and dysfunction of endothelial nitric oxide synthase in coronary arteries. Circulation 91(1):139–144
Heitzer T, Yla-Herttuala S, Luoma J, Kurz S, Munzel T, Just H, et al (1996) Cigarette smoking potentiates endothelial dysfunction of forearm resistance vessels in patients with hypercholesterolemia. Role of oxidized LDL. Circulation 93(7):1346–1353
Heitzer T, Just H, Munzel T (1996) Antioxidant vitamin C improves endothelial dysfunction in chronic smokers. Circulation 94(1):6–9
Celermajer DS, Sorensen KE, Georgakopoulos D, Bull C, Thomas O, Robinson J, et al (1993) Cigarette smoking is associated with dose-related and potentially reversible impairment of endothelium-dependent dilation in healthy young adults. Circulation 88(5 Pt 1):2149–2155
Higman DJ, Strachan AM, Powell JT (1994) Reversibility of smoking-induced endothelial dysfunction. Br J Surg 81(7):977–978
Lassila R, Seyberth HW, Haapanen A, Schweer H, Koskenvuo M, Laustiola KE (1988) Vasoactive and atherogenic effects of cigarette smoking: a study of monozygotic twins discordant for smoking. BMJ 297(6654):955–957
He JF (1991) Morphologic and morphometric studies of pulmonary artery endothelial abnormalities in rats induced by smoking. Zhonghua Bing Li Xue Za Zhi 20(3):165–168
Lin SJ, Hong CY, Chang MS, Chiang BN, Chien S (1992) Long-term nicotine exposure increases aortic endothelial cell death and enhances transendothelial macromolecular transport in rats. Arterioscler Thromb 12(11):1305–1312
Zimmerman M, McGeachie J (1987) The effect of nicotine on aortic endothelium. A quantitative ultrastructural study. Atherosclerosis 63(1):33–41
Tithof PK, Elgayyar M, Schuller HM, Barnhill M, Andrews R (2001) 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, a nicotine derivative, induces apoptosis of endothelial cells. Am J Physiol Heart Circ Physiol 281(5):H1946–H1954
Bernhard D, Pfister G, Huck CW, Kind M, Salvenmoser W, Bonn GK, et al (2003) Disruption of vascular endothelial homeostasis by tobacco smoke: impact on atherosclerosis. FASEB J 17(15):2302–2304
Kiowski W, Linder L, Stoschitzky K, Pfisterer M, Burckhardt D, Burkart F, et al (1994) Diminished vascular response to inhibition of endothelium-derived nitric oxide and enhanced vasoconstriction to exogenously administered endothelin-1 in clinically healthy smokers. Circulation 90(1):27–34
Brush JE Jr, Faxon DP, Salmon S, Jacobs AK, Ryan TJ (1992) Abnormal endothelium-dependent coronary vasomotion in hypertensive patients. J Am Coll Cardiol 19(4): 809–815
Drexler H, Zeiher AM (1991) Endothelial function in human coronary arteries in vivo. Focus-on hypercholesterolemia. Hypertension 18(Suppl 4):II90–II99
Seiler C, Hess OM, Buechi M, Suter TM, Krayenbuehl HP (1993) Influence of serum cholesterol and other coronary risk factors on vasomotion of angiographically normal coronary arteries. Circulation 88(5 Pt 1):2139–2148
Hashimoto H (1994) Impaired microvascular vasodilator reserve in chronic cigarette smokers – a study of post-occlusive reactive hyperemia in the human finger. Jpn Circ J 58(1):29–33
Ottervanger JP, Festen JM, de Vries AG, Stricker BH (1995) Acute myocardial infarction while using the nicotine patch. Chest 107(6):1765–1766
Sabha M, Tanus-Santos JE, Toledo JC, Cittadino M, Rocha JC, Moreno H Jr (2000) Transdermal nicotine mimics the smoking-induced endothelial dysfunction. Clin Pharmacol Ther 68(2):167–174
Belch JJ, McArdle BM, Burns P, Lowe GD, Forbes CD (1984) The effects of acute smoking on platelet behaviour, fibrinolysis and haemorheology in habitual smokers. Thromb Haemost 51(1):6–8
Eliasson M, Asplund K, Evrin PE, Lundblad D (1995) Relationship of cigarette smoking and snuff dipping to plasma fibrinogen, fibrinolytic variables and serum insulin. The Northern Sweden MONICA Study. Atherosclerosis 113(1):41–53
Feher MD, Rampling MW, Brown J, Robinson R, Richmond W, Cholerton S ,et al (1990) Acute changes in atherogenic and thrombogenic factors with cessation of smoking. J R Soc Med 83(3):146–148
Dal Bianco P, Zeiler K, Baumgartner C, Kollegger H, Oder W Deecke L (1989) Use of nicotine – a risk factor for stroke? Wien Klin Wochenschr 101(20):687–694
Salbas K (1994) Effect of acute smoking on red blood cell deformability in healthy young and elderly non-smokers, and effect of verapamil on age- and acute smoking-induced change in red blood cell deformability. Scand J Clin Lab Invest 54(6):411–416
Salbas K, Gurlek A, Akyol T (1994) In vitro effect of nicotine on red blood cell deformability in untreated and treated essential hypertension. Scand J Clin Lab Invest 54(8):659–663
Blann AD (1992) The acute influence of smoking on the endothelium. Atherosclerosis 96(2–3):249–250
Calori G, D’Angelo A, Della VP, Ruotolo G, Ferini-Strambi L, Giusti C, et al (1996) The effect of cigarette-smoking on cardiovascular risk factors: a study of monozygotic twins discordant for smoking. Thromb Haemost 75(1):14–18
Thomas GA, Davies SV, Rhodes J, Russell MA, Feyerabend C, Sawe U (1995) Is transdermal nicotine associated with cardiovascular risk? J R Coll Physicians Lond 29(5):392–396
Blann AD, Steele C, McCollum CN (1997) The influence of smoking and of oral and transdermal nicotine on blood pressure, and haematology and coagulation indices. Thromb Haemost 78(3):1093–1096
Miller GJ, Esnouf MP, Burgess AI, Cooper JA, Mitchell JP (1997) Risk of coronary heart disease and activation of factor XII in middle-aged men. Arterioscler Thromb Vasc Biol 17(10):2103–2106
Heeschen C, Jang JJ, Weis M, Pathak A, Kaji S, Hu RS, et al (2001) Nicotine stimulates angiogenesis and promotes tumor growth and atherosclerosis. Nat Med 7:833–839
Mosely LH, Finseth F (1977) Cigarette smoking: impairment of digital blood flow and wound healing in the hand. Hand 9(2):97–101
Mosely LH, Finseth F, Goody M (1978) Nicotine and its effect on wound healing. Plast Reconstr Surg 61(4):570–575
Nolan J, Jenkins RA, Kurihara K, Schultz RC (1985) The acute effects of cigarette smoke exposure on experimental skin flaps. Plast Reconstr Surg 75(4):544–551
Riefkohl R, Wolfe JA, Cox EB, McCarty KS Jr (1986) Association between cutaneous occlusive vascular disease, cigarette smoking, and skin slough after rhytidectomy. Plast Reconstr Surg 77(4):592–595
Harris GD, Finseth F, Buncke HJ (1980) The hazard of cigarette smoking following digital replantation. J Microsurg 1(5):403–404
Wilson GR, Jones BM (1984) The damaging effect of smoking on digital revascularisation: two further case reports. Br J Plast Surg 37(4):613–614
Dardour JC, Pugash E, Aziza R (1988) The one-stage preauricular flap for male pattern baldness: long-term results and risk factors. Plast Reconstr Surg 81(6):907–912
Rees TD, Liverett DM, Guy CL (1984) The effect of cigarette smoking on skin-flap survival in the face lift patient. Plast Reconstr Surg 73(6):911–915
Craig S, Rees TD (1985) The effects of smoking on experimental skin flaps in hamsters. Plast Reconstr Surg 75(6):842–846
Lawrence WT, Murphy RC, Robson MC, Heggers JP (1984) The detrimental effect of cigarette smoking on flap survival: an experimental study in the rat. Br J Plast Surg 37(2):216–219
Dalla VL, Palombo C, Ciardetti M, Porta A, Milani O, Kozakova M, et al (2004) Contrasting effects of acute and chronic cigarette smoking on skin microcirculation in young healthy subjects. J Hypertens 22(1):129–135
Ijzerman RG, Serne EH, van Weissenbruch MM, de Jongh RT, Stehouwer CD (2003) Cigarette smoking is associated with an acute impairment of microvascular function in humans. Clin Sci (Lond) 104(3):247–252
Roth GM, McDonald JB, Sheard C (1944) The effect of smoking cigarettes and of intravenous administration of nicotine on the eletrocardiogram, banal metabolic rate, cutaneous temperature, blood pressure and pulse rate of normale persons. J Am med Ass 125:761–767
Richardson DR (1985) Effects of habitual tobacco smoking on reactive hyperemia in the human hand. Arch Environ Health 40(2):114–119
Suter TW, Buzzi R, Battig K (1983) Cardiovascular effects of smoking cigarettes with different nicotine deliveries. A study using multilead plethysmography. Psychopharmacology (Berl) 80(2):106–112
Leow YH, Maibach HI (1998) Cigarette smoking, cutaneous vasculature, and tissue oxygen. Clin Dermatol 16(5):579–584
Bounameaux H, Griessen M, Benedet P, Krahenbuhl B, Deom A (1988) Nicotine induced haemodynamic changes during cigarette smoking and nicotine gum chewing: a placebo controlled study in young healthy volunteers. Cardiovasc Res 22(2):154–158
Netscher DT, Wigoda P, Thornby J, Yip B, Rappaport NH (1995) The hemodynamic and hematologic effects of cigarette smoking versus a nicotine patch. Plast Reconstr Surg 96(3):681–688
Jensen JA, Goodson WH, Hopf HW, Hunt TK (1991) Cigarette smoking decreases tissue oxygen. Arch Surg 126(9):1131–1134
Model D (1985) Smoker’s face: an underrated clinical sign? Br Med J (Clin Res Ed) 291(6511):1760–1762
Meade TW, Imeson J, Stirling Y (1987) Effects of changes in smoking and other characteristics on clotting factors and the risk of ischaemic heart disease. Lancet 2(8566):986–988
Adams KF, Koch G, Chatterjee B, Goldstein GM, O’Neil JJ, Bromberg PA, et al (1988) Acute elevation of blood carboxyhemoglobin to 6% impairs exercise performance and aggravates symptoms in patients with ischemic heart disease. J Am Coll Cardiol 12(4):900–909
Allred EN, Bleecker ER, Chaitman BR, Dahms TE, Gottlieb SO, Hackney JD, et al (1989) Short-term effects of carbon monoxide exposure on the exercise performance of subjects with coronary artery disease. N Engl J Med 321(21):1426–1432
Davies MJ, Woolf N (1993) Atherosclerosis: what is it and why does it occur? Br Heart J 69(Suppl 1):S3–S11
Tsao PS, Lewis NP, Alpert S, Cooke JP (1995) Exposure to shear stress alters endothelial adhesiveness. Role of nitric oxide. Circulation 92(12):3513–3519
Cavusoglu Y, Timuralp B, Us T, Akgun Y, Kudaiberdieva G, Gorenek B, et al (2004) Cigarette smoking increases plasma concentrations of vascular cell adhesion molecule-1 in patients with coronary artery disease. Angiology 55(4):397–402
Zapolska-Downar D, Naruszewicz M, Zapolski-Downar A, Markiewski M, Bukowska H, Millo B (2000) Ibuprofen inhibits adhesiveness of monocytes to endothelium and reduces cellular oxidative stress in smokers and non-smokers. Eur J Clin Invest 30(11):1002–1010
Shen Y, Rattan V, Sultana C, Kalra VK (1996) Cigarette smoke condensate-induced adhesion molecule expression and transendothelial migration of monocytes. Am J Physiol 270(5 Pt 2):H1624–H1633
Weber C, Erl W, Weber K, Weber PC (1996) Increased adhesiveness of isolated monocytes to endothelium is prevented by vitamin C intake in smokers. Circulation 93(8):1488–1492
Wang Y, Wang L, Ai X, Zhao J, Hao X, Lu Y, et al (2004) Nicotine could augment adhesion molecule expression in human endothelial cells through macrophages secreting TNF-alpha, IL-1beta. Int Immunopharmacol 4(13):1675–1686
Caro CG, Lever MJ, Parker KH, Fish PJ (1987) Effect of cigarette smoking on the pattern of arterial blood flow: possible insight into mechanisms underlying the development of arteriosclerosis. Lancet 2(8549):11–13
Ernst E, Matrai A, Schmolzl C, Magyarosy I (1987) Dose-effect relationship between smoking and blood rheology. Br J Haematol 65(4):485–487
Resnick N, Gimbrone MA Jr (1995) Hemodynamic forces are complex regulators of endothelial gene expression. FASEB J 9(10):874–882
Sbarbati R, de Boer M, Marzilli M, Scarlattini M, Rossi G, van Mourik JA (1991) Immunologic-detection of endothelial cells in human whole blood. Blood 77(4):764–769
Jeng JR (2000) Carotid thickening, cardiac hypertrophy, and angiotensin converting enzyme gene polymorphism in patients with hypertension. Am J Hypertens 13(1 Pt 1):111–119
Schut AF, Sayed-Tabatabaei FA, Witteman JC, Avella AM, Vergeer JM, Pols HA, et al (2004) Smoking-dependent effects of the angiotensin-converting enzyme gene insertion/deletion polymorphism on blood pressure. J Hypertens 22(2):313–319
Whisnant JP, Homer D, Ingall TJ, Baker HL Jr, O’Fallon WM, Wievers DO (1990) Duration of cigarette smoking is the strongest predictor of severe extracranial carotid artery atherosclerosis. Stroke 21(5):707–714
Fuster V, Chesebro JH, Frye RL, Elveback LR (1981) Platelet survival and the development of coronary artery disease in the young adult: effects of cigarette smoking, strong family history and medical therapy. Circulation 63(3):546–551
Nowak J, Murray JJ, Oates JA, Fitzgerald GA (1987) Biochemical evidence of a chronic abnormality in platelet and vascular function in healthy individuals who smoke cigarettes. Circulation 76(1):6–14
Benowitz NL, Fitzgerald GA, Wilson M, Zhang Q (1993) Nicotine effects on eicosanoid formation and hemostatic function: comparison of transdermal nicotine and cigarette smoking. J Am Coll Cardiol 22(4):1159–1167
Montalescot G, Ankri A, Vicaut E, Drobinski G, Grosgogeat Y, Thomas D (1995) Fibrinogen after coronary angioplasty as a risk factor for restenosis. Circulation 92(1):31–38
Wiseman S, Kenchington G, Dain R, Marshall CE, McCollum CN, Greenhalgh RM, et al (1989) Influence of smoking and plasma factors on patency of femoropopliteal vein grafts. BMJ 299(6700):643–646
Mazoyer E, Drouet L, Soria C, Fruchard JC, Pellerin A, Arcan JC, et al (1999) Risk factors and outcomes for atherothrombotic disease in French patients: the RIVAGE study. RIsque VAsculaire Group d’Etude. Thromb Res 95:163–176
Pellegrini MP, Newby DE, Maxwell S, Webb DJ (2001) Short-term effects of transdermal nicotine on acute tissue plasminogen activator release in vivo in man. Cardiovasc Res 52(2):3 21–327
Newby DE, McLeod AL, Uren NG, Flint L, Ludlam CA, Webb DJ, et al (2001) Impaired coronary tissue plasminogen activator release is associated with coronary atherosclerosis and cigarette smoking: direct link between endothelial dysfunction and atherothrombosis. Circulation 103(15):1936–1941
Languino LR, Plescia J, Duperray A, Brian AA, Plow EF, Geltosky JE, et al (1993) Fibrinogen mediates leukocyte adhesion to vascular endothelium through an ICAM-1-dependent pathway. Cell 73(7):1423–1434
Qi J, Kreutzer DL (1995) Fibrin activation of vascular endothelial cells. Induction of IL-8 expression. J Immunol 155(2):867–876
Joensuu T, Salonen R, Winblad I, Korpela H, Salonen JT (1994) Determinants of femoral and carotid artery atherosclerosis. J Intern Med 236(1):79–84
Freeman DJ, Griffin BA, Holmes AP, Lindsay GM, Gaffney D, Packard CJ, et al (1994) Regulation of plasma HDL cholesterol and subfraction distribution by genetic and environmental factors. Associations between the TaqI B RFLP in the CETP gene and smoking and obesity. Arterioscler Thromb 14(3):336–344
Reilly SL, Ferrell RE, Kottke BA, Sing CF (1992) The gender-specific apolipoprotein E genotype influence on the distribution of plasma lipids and apolipoproteins in the population of Rochester, Minnesota. II. Regression relationships with concomitants. Am J Hum Genet 51(6):1311–1324
Behague I, Poirier O, Nicaud V, Evans A, Arveiler D, Luc G, et al (1996) Beta fibrinogen gene polymorphisms are associated with plasma fibrinogen and coronary artery disease in patients with myocardial infarction. The ECTIM Study. Etude Cas-Temoins sur l’Infarctus du Myocarde. Circulation 93(3):440–449
Thomas AE, Green FR, Kelleher CH, Wilkes HC, Brennan PJ, Meade TW, et al (1991) Variation in the promoter region of the beta fibrinogen gene is associated with plasma fibrinogen levels in smokers and non-smokers. Thromb Haemost 65(5):487–490
Wang XL, Sim AS, Badenhop RF, McCredie RM, Wilcken DE (1996) A smoking-dependent risk of coronary artery disease associated with a polymorphism of the endothelial nitric oxide synthase gene. Nat Med 2(1):41–45
Joseph AM, Norman SM, Ferry LH, Prochazka AV, Westman EC, Steele BG, et al (1996) The safety of transdermal nicotine as an aid to smoking cessation in patients with cardiac disease. N Engl J Med 335(24):1792–1798
Murray RP, Bailey WC, Daniels K, Bjornson WM, Kurnow K, Connett JE, et al (1996) Safety of nicotine polacrilex gum used by 3,094 participants in the Lung Health Study. Lung Health Study Research Group. Chest 109(2):438–445
Dacosta A, Guy JM, Tardy B, Gonthier R, Denis L, Lamaud M, et al (1993) Myocardial infarction and nicotine patch: a contributing or causative factor? Eur Heart J 14(12):1709–1711
Fredrickson PA, Hurt RD, Lee GM, Wingender L, Croghan IT, Lauger G, et al (1995) High dose transdermal nicotine therapy for heavy smokers: safety, tolerability and measurement of nicotine and cotinine levels. Psychopharmacology (Berl) 122(3):215–222
Jackson M (1993) Cerebral arterial narrowing with nicotine patch. Lancet 342(8865):236–237
Stewart RD, Stewart RS, Stamm W, Seelen RP (1976) Rapid estimation of carboxyhemoglobin level in fire fighters. JAMA 235(4):390–392
Anon (1994) Nicotine replacement therapy for patients with coronary artery disease. Working group for the study of transdermal nicotine in patients with coronary artery disease. Arch Intern Med 154(9):989–995
Ayanian JZ, Cleary PD (1999) Perceived risks of heart disease and cancer among cigarette smokers. JAMA 281(11):1019–1021
Kilaru S, Frangos SG, Chen AH, Gortler D, Dhadwal AK, Araim O, et al (2001) Nicotine: a review of its role in atherosclerosis. J Am Coll Surg 193(5):538–546
Jodoin I, Bussieres LM, Tardif JC, Juneau M (1999) Effect of a short-term primary prevention program on endothelium-dependent vasodilation in adults at risk for atherosclerosis. Can J Cardiol 15:83–88
Iso H, Shimamoto T, Sato S, Koike K, Iida M, Komachi Y (1996) Passive smoking and plasma fibrinogen concentrations. Am J Epidemiol 144(12):1151–1154
Kannel WB, D’Agostino RB, Belanger AJ (1987) Fibrinogen, cigarette smoking, and risk of cardiovascular disease: insights from the Framingham study. Am Heart J 113(4): 1006–1010
Lowe GD, Fowkes FG, Dawes J, Donnan PT, Lennie SE, Housley E (1993) Blood viscosity, fibrinogen, and activation of coagulation and leukocytes in peripheral arterial disease and the normal population in the Edinburgh artery study. Circulation 87(6):1915–1920
Allen DR, Browse NL, Rutt DL (1989) Effects of cigarette smoke, carbon monoxide and nicotine on the uptake of fibrinogen by the canine arterial wall. Atherosclerosis 77(1):83–88
Allen DR, Browse NL, Rutt DL, Butler L, Fletcher C (1988) The effect of cigarette smoke, nicotine, and carbon monoxide on the permeability of the arterial wall. J Vasc Surg 7(1):139–152
Marshall M, Hess H (1981) Acute effects of low carbon monoxide concentrations on blood rheology, platelet fuction, and the arterial wall in the minipig (author’s transl). Res Exp Med (Berl) 178(3):201–210
Powell JT (1998) Vascular damage from smoking: disease mechanisms at the arterial wall. Vasc Med 3(1):21–28
Tur E, Yosipovitch G, Oren-Vulfs S (1992) Chronic and acute effects of cigarette smoking on skin blood flow. Angiology 43(4):328–335
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Haustein, KO., Groneberg, D. (2010). Cardiovascular Disease, Disturbances of Blood Coagulation and Fibrinolysis. In: Tobacco or Health?. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-87577-2_6
Download citation
DOI: https://doi.org/10.1007/978-3-540-87577-2_6
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-87576-5
Online ISBN: 978-3-540-87577-2
eBook Packages: MedicineMedicine (R0)